Association of the μ-opioid receptor gene with type 2 diabetes mellitus in an African American population

Molecular Genetics and Metabolism

Volumn 87, Issue 1, 2006, Pages 54-60

  Gallagher, Carla J ^a   Gordon, Candace J ^a   Langefeld, Carl D ^a   Mychaleckyj, Josyf C ^a   Freedman, Barry I ^a   Rich, Stephen S ^a   Bowden, Donald W ^a   Sale, Michèle M ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

African American; Association; Haplotype; Opioid receptor; Positional cloning; Type 2 diabetes

Indexed keywords

MU OPIATE RECEPTOR;

AFRICAN AMERICAN; ARTICLE; CONTROLLED STUDY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RECEPTOR GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

AFRICAN AMERICANS; DIABETES MELLITUS, TYPE 2; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; KIDNEY FAILURE, CHRONIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, OPIOID, MU;

EID: 29344469072     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2005.07.013     Document Type: Article

References (31)

1. F.L. Brancati, W.H. Kao, A.R. Folsom, R.L. Watson, and M. Szklo Incident type 2 diabetes mellitus in African American and white adults: the Atherosclerosis Risk in Communities Study JAMA 283 2000 2253 2259
2. National Diabetes Information Clearinghouse (2002). "National Diabetes Statistics," National Institutes of Diabetes and Digestive Kidney Diseases, Bethesda, MD.
3. M.M. Sale, B.I. Freedman, C.D. Langefeld, A.H. Williams, P.J. Hicks, C.J. Colicigno, S.R. Beck, W.M. Brown, S.S. Rich, and D.W. Bowden A genome-wide scan for type 2 diabetes in African-American families reveals evidence for a locus on chromosome 6q Diabetes 53 2004 830 837
4. M. Zhang, M. Zheng, and R.L. Schleicher Autoradiographic localization of beta-endorphin binding in the pancreas Mol. Cell. Neurosci. 5 1994 684 690
5. J.T. Cheng, I.M. Liu, and C.F. Hsu Rapid induction of insulin resistance in opioid mu-receptor knock-out mice Neurosci. Lett. 339 2003 139 142
6. X.Z. Khawaja, I.C. Green, J.R. Thorpe, and M.A. Titheradge The occurrence and receptor specificity of endogenous opioid peptides within the pancreas and liver of the rat. Comparison with brain Biochem. J. 267 1990 233 240
7. K. Josefsen, K. Buschard, L.R. Sorensen, M. Wollike, R. Ekman, and M. Birkenbach Glucose stimulation of pancreatic beta-cell lines induces expression and secretion of dynorphin Endocrinology 139 1998 4329 4336
8. B. Ahren Effects of beta-endorphin, met-enkephalin, and dynorphin A on basal and stimulated insulin secretion in the mouse Int. J. Pancreatol. 5 1989 165 178
9. Y. Cetin Immunohistochemistry of opioid peptides in the guinea pig endocrine pancreas Cell Tissue Res. 259 1990 313 319
10. D. Giugliano, D. Cozzolino, T. Salvatore, R. Torella, and F. D'Onofrio Beta-endorphin-induced inhibition and stimulation of insulin secretion in normal humans is glucose dependent Diabetes 37 1988 1265 1270
11. M.J. Garcia-Barrado, M.C. Iglesias-Osma, R. Rodriguez, M. Martin, and J. Moratinos Role of mu-opioid receptors in insulin release in the presence of inhibitory and excitatory secretagogues Eur. J. Pharmacol. 448 2002 95 104
12. R.L. Schleicher Beta-endorphin inhibits insulin secretion from isolated pancreatic islets Endocrinology 124 1989 1254 1258
13. R.L. Reid, and S.S. Yen Beta-endorphin stimulates the secretion of insulin and glucagon in humans J. Clin. Endocrinol. Metab. 52 1981 592 594
14. I.C. Green, K. Ray, and D. Perrin Opioid peptide effects on insulin release and c-AMP in islets of Langerhans Horm. Metab. Res. 15 1983 124 128
15. I.C. Green, D. Perrin, E. Penman, A. Yaseen, K. Ray, and S.L. Howell Effect of dynorphin on insulin and somatostatin secretion, calcium uptake, and c-AMP levels in isolated rat islets of Langerhans Diabetes 32 1983 685 690
16. I.C. Green, and M. Tadayyon Opiate-prostaglandin interactions in the regulation of insulin secretion from rat islets of Langerhans in vitro Life Sci. 42 1988 2123 2130
17. J. Ishizuka, T. Toyota, T. Ono, M. Sasaki, C. Yanaihara, and N. Yanaihara Inhibitory effects of rimorphin and dynorphin on insulin secretion from the isolated, perfused rat pancreas Tohoku J. Exp. Med. 150 1986 17 24
18. Y. Li, S. Eitan, J. Wu, C.J. Evans, B. Kieffer, X. Sun, and R.D. Polakiewicz Morphine induces desensitization of insulin receptor signaling Mol. Cell. Biol. 23 2003 6255 6266
19. M.R. Hoehe, K. Kopke, B. Wendel, K. Rohde, C. Flachmeier, K.K. Kidd, W.H. Berrettini, and G.M. Church Sequence variability and candidate gene analysis in complex disease: association of mu opioid receptor gene variation with substance dependence Hum. Mol. Genet. 9 2000 2895 2908
20. K.H. Buetow, M. Edmonson, R. MacDonald, R. Clifford, P. Yip, J. Kelley, D.P. Little, R. Strausberg, H. Koester, C.R. Cantor, and A. Braun High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry Proc. Natl. Acad. Sci. USA 98 2001 581 584
21. J.C. Barrett, B. Fry, J. Maller, and M.J. Daly Haploview: analysis and visualization of LD and haplotype maps Bioinformatics 21 2005 263 265
22. L.E. Green, E.M. Lange, and C.D. Langefeld Power comparisions of phase-known versus phase-unknown haplotype analyses for case-control designs Am. J. Hum. Genet. 69 2001 1948a
23. D.W. Bowden, C.J. Colicigno, C.D. Langefeld, M.M. Sale, A. Williams, P.J. Anderson, S.S. Rich, and B.I. Freedman A genome scan for diabetic nephropathy in African Americans Kidney Int. 66 2004 1517 1526
24. B.I. Freedman, A.B. Tuttle, and B.J. Spray Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus Am. J. Kidney Dis. 25 1995 710 713
25. C. Rotimi, R. Cooper, G. Cao, C. Sundarum, and D. McGee Familial aggregation of cardiovascular diseases in African-American pedigrees Genet. Epidemiol. 11 1994 397 407
26. C. Bond, K.S. LaForge, M. Tian, D. Melia, S. Zhang, L. Borg, J. Gong, J. Schluger, J.A. Strong, S.M. Leal, J.A. Tischfield, M.J. Kreek, and L. Yu Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction Proc. Natl. Acad. Sci. USA 95 1998 9608 9613
27. Y.X. Pan, J. Xu, L. Mahurter, E. Bolan, M. Xu, and G.W. Pasternak Generation of the mu opioid receptor (MOR-1) protein by three new splice variants of the Oprm gene Proc. Natl. Acad. Sci. USA 98 2001 14084 14089
28. P. Cadet Mu opiate receptor subtypes Med. Sci. Monit. 10 2004 MS28 MS32
29. L. Pan, J. Xu, R. Yu, M.M. Xu, Y.X. Pan, and G.W. Pasternak Identification and characterization of six new alternatively spliced variants of the human mu opioid receptor gene Oprm. Neuroscience 133 2005 209 220
30. V. Brendel, L. Xing, and W. Zhu Gene structure prediction from consensus spliced alignment of multiple ESTs matching the same genomic locus Bioinformatics 20 2004 1157 1169
31. J.C. Long The genetic structure of admixed populations Genetics 127 1991 417 428